PSP Research »

Royalty Pharma shares owned by PSP Research

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by PSP Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $534k 14k 38.64

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Praxis Precision Medicines I Com New (PRAX)
Travere Therapeutics (TVTX)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Celldex Therapeutics Com New (CLDX)
Cg Oncology (CGON)
Belite Bio Sponsored Ads (BLTE)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)

View all positions for PSP Research

Top funds holding Royalty Pharma

Capital Research and Management Company - Division 3
FMR
BlackRock
Baillie Gifford & Co
Swedbank AB
Adage Capital Partners GP
State Street Corporation
Vanguard Group
Geode Capital Management
Caledonia
Citadel Advisors
Victory Capital Management
Jane Street
Northern Trust
Norges Bank Investment Management

View all funds holding Royalty Pharma